What's Going On With Annovis Shares Today?
What's Going On With Annovis Shares Today?
Annovis Bio, Inc. (NYSE:ANVS) stock is showing gains during premarket trading on Wednesday, following a significant increase of more than 76% in the previous session.
週三盤前交易中，Annovis Bio, Inc. (紐交所代碼：ANVS)的股票正在上漲，此前一天股價大幅增長了76%以上。
According to Benzinga Pro, ANVS stock has lost over 34% in the past year.
據Benzinga Pro報道，ANVS股票在過去一年中下跌了超過34%。
Rodman & Renshaw analyst Elemer Piros reiterates Annovis Bio with a Buy and maintains a $67 price target.
羅德曼與雷恩肖分析師Elemer Piros重申Annovis Bio股票的買入評級，並保持67美元的目標價格。
The company announced new data from its Phase III Parkinson's study.
該公司宣佈了其第三期帕金森病研究的新數據。
The study showed improvements on the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) following treatment with buntanetap.
該研究表明，在使用布坦氮單抗治療後，在MDS-UPDRS評分量表上出現了改善。
The findings demonstrated that the placebo group experienced cognitive deterioration throughout the study, whereas the treatment groups experienced no further deterioration.
研究結果表明，安慰劑組在研究期間出現認知惡化，而治療組未出現進一步惡化。
"These compelling data reinforce our commitment to advancing buntanetap into a longer study, which will allow us not only to verify observed symptomatic improvements but also to explore buntanetap's disease-modifying properties," said Maria Maccecchini, Ph.D., Founder, President and CEO of Annovis Bio.
Annovis Bio的創始人、總裁兼首席執行官Maria Maccecchini博士表示:"這些令人信服的數據加強了我們將布坦氮單抗推進到更長時間研究的承諾，這將使我們不僅能夠驗證觀察到的症狀改善，而且還能夠探索布坦氮單抗的疾病修復性質。
On June 27, the firm announced the filing of a provisional patent covering the manufacturing process of new solid forms of buntanetap.
6月27日，該公司宣佈申請關於新型布坦氮單抗固體形態製造工藝的臨時專利。
This patent encompasses the methods for manufacturing the new crystalline form of buntanetap, which has demonstrated exceptional stability and efficacy.
該專利囊括了製造新的布坦氮單抗結晶形態的方法，這種方法表現出卓越的穩定性和功效。
The patent also covers the entire synthesis process, from basic starting materials to finished (>99.9% pure) GMP product, suitable for manufacturing scale at ton quantities.
該專利還覆蓋了整個合成過程，從基本起始物質到完成(>99.9%純度)GMP產品，適合於在噸量尺度上進行生產。
Price Action: ANVS shares are trading higher by 6.79% to $9.90 premarket at last check Wednesday.
ANVS股票今日盤前最新交易價格爲9.9美元，較上一交易日增長了6.79%。
Photo via Shutterstock
圖片來自shutterstock。
- JP Morgan Appoints Nazim Ali To Lead Asia Tech Vertical In Private Bank Expansion: Report
- JP摩根任命納齊姆·阿里領導亞洲技術垂直領域，擴展私人銀行業務:報告
譯文內容由第三人軟體翻譯。